Shire rebrands Advanced BioHealing division

Shire has announced that its Advanced BioHealing division will undergo rebranding in order to align its corporate identity more closely with its parent company.

The business has been renamed Shire Regenerative Medicine effective immediately, with wider rebranding efforts to be completed by the end of 2012.

Shire Regenerative Medicine will continue to focus on developing and delivering treatments that support the body's natural healing process, including products such as Dermagraft and Vascugel.

Kevin Rakin, president of Shire Regenerative Medicine, said: "We aspire to address society's unmet medical needs by harnessing the power of regenerative medicine, both within our own development activities as well as those of companies we partner with."

This move follows the recent announcement that Shire will be building a new regenerative medicine campus in San Diego, allowing it to expand its presence in the region over the coming years.

It will also help the company to meet the expected future rise in demand for its lead product Dermagraft, which is used in the treatment of full-thickness diabetic foot ulcers.